FMC Corporation (FMC) is a Philadelphia-based agricultural sciences company that sells insecticides, herbicides, fungicides and biological crop-protection products across North and Latin America, Europe, the Middle East and Asia. Its shares fell 6.62% on Thursday to $4.37, compared with the previous session's close of $4.68. The direction was unambiguously lower, and the move carried the stock beneath its October 28 low to a fresh 52-week bottom. Unlike the double-digit selloffs of mid-October, Thursday's decline arrived without a new earnings release, guidance update or headline catalyst.
No verified news or fundamental catalyst found for Thursday's session. The decline is most consistent with a market that remains in price-discovery mode after a balance-sheet shock, with sellers pressing a thinly traded, deeply distressed equity toward new lows and few buyers willing to catch the falling knife. Two data points support that reading: the stock is roughly 1.5 times more volatile than its own recent baseline, averaging a 4.40% absolute daily move over the last 60 sessions, and it has now fallen in three straight sessions from $5.23 to $4.37 — a pattern of sustained distribution rather than a single-event repricing.
The drivers that have pushed the stock down are verified and previously disclosed, even if none of them broke on Thursday. On October 15, FMC slashed its third-quarter revenue outlook to $65 million–$125 million from $840 million–$900 million and projected an adjusted EBITDA loss of $510 million–$565 million, citing $625 million–$675 million in commercial actions to lower prices on products held by distributors and to revamp its U.S. selling model. Third-quarter results on October 29 confirmed the damage: revenue of $105.9 million, an adjusted loss of $4.41 per share and a GAAP net loss of $2.07 billion that included an $808.8 million deferred-tax valuation allowance and a $287.5 million intangible impairment.
On November 5, S&P Global Ratings cut FMC's issuer credit rating two notches to BB- from BB+ with a negative outlook, citing weak demand, generic competition and credit measures inconsistent with the prior rating, and lowered the unsecured debt rating to B+. Management has flagged discussions with lenders over covenant flexibility, with a leverage test returning on December 31. KeyBanc subsequently downgraded the shares to Sector Weight from Overweight on November 16, arguing the deteriorating market gives FMC roughly one more year to execute its recovery before harsher steps, including additional equity issuance, become likely. Several law firms have also opened securities investigations tied to the guidance collapse.
Liquidity is meaningful but not panicked. Recent sessions have seen turnover of roughly 5 million to 11 million shares, against a three-month average near 5.5 million, so activity has been elevated but well short of the 32.6 million shares that changed hands on October 15. The move appears to be stock-specific: the pressure stems from FMC's own leverage, pricing reset and credit standing rather than from a broad macro or agricultural-commodity event. Technically, the picture is weak across timeframes. The shares have traded below a declining 200-day moving average, printed a death cross in which the 50-day crossed beneath the 200-day, and now sit at new lows with the $5.00 and $5.20 areas having flipped from support to resistance. Market value is roughly $580 million.
The score runs from 0, meaning no meaningful news and a move that is normal for the stock, to 100, meaning transformative news and an extreme, rare move. FMC scores 18 out of 100. No verified news was found for Thursday, so the catalyst component is weak despite the genuine severity of the October guidance reset and the credit downgrade already in the public domain. The price component is also muted: the 6.62% decline was about 1.5 times the stock's typical 4.40% absolute daily move, and a move of that size or larger has occurred seven times in the last 60 sessions. Two weak components combine into a low score.
Attention turns to the fourth quarter, for which FMC has guided revenue of $1.04 billion to $1.14 billion and adjusted EBITDA of $210 million to $230 million, with adjusted earnings of $0.56 to $0.70 per share. Full-year free cash flow is expected to land between negative $350 million and negative $150 million, and the December 31 leverage covenant test is the nearest hard catalyst. Investors will also watch asset-sale and licensing progress toward the targeted $1 billion debt reduction, including the Indian operations divestiture, along with commentary on distributor inventory levels, generic pricing pressure in Latin America and any amendment to lender agreements. Management's preliminary 2027 adjusted EBITDA framework of $650 million to $730 million is not formal guidance and remains a key source of uncertainty, as does the risk of further impairment charges or additional equity issuance.
Tickeron's Trending AI Robots page offers a curated view of the platform's strongest automated strategies. Tickeron maintains hundreds of AI trading bots covering thousands of tickers, but only those performing best under current market conditions earn a place in this featured section. Bots differ widely by strategy, timeframe, performance metrics and the symbols they trade, which makes the curated list a practical starting point for comparing approaches. Explore the Trending AI Robots selection to see which strategies are currently leading.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Oscillator for FMC moved out of oversold territory on October 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In 21 of the 34 cases the stock moved higher. This puts the odds of a move higher at 62%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for FMC just turned positive on October 30, 2026. Looking at past instances where FMC's MACD turned positive, the stock continued to rise in 29 of 47 cases over the following month. The odds of a continued upward trend are 62%.
Following a +3.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where FMC advanced for three days, in 173 of 288 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
FMC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FMC as a result. In 60 of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 69%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.
The Aroon Indicator for FMC entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 10 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.535) is normal, around the industry mean (-0.492). P/E Ratio (-0.256) is within average values for comparable stocks, (8.794). Projected Growth (PEG Ratio) (1.532) is also within normal values, averaging (0.867). Dividend Yield (0.057) settles around the average of (0.113) among similar stocks. P/S Ratio (0.416) is also within normal values, averaging (1.476).
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. FMC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FMC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a developer of industrial, specialty and agricultural chemicals
Industry ChemicalsAgricultural